Deal Updates | Business Events | Networking | Special Offers & Much More...
Deal Type
Industry
Deal Status
Investor Mandate: ₹50–400 Cr Growth Capital for Healthcare Platforms | Hospitals, Pharma & Medical Devices
An investor is actively looking to deploy ₹50–400 Cr in growth-stage healthcare businesses across:
• Hospital platforms (multi-specialty / single-specialty chains)
• Pharmaceutical companies (branded generics, specialty pharma)
• Medical devices & diagnostic equipment players
Investment parameters:
• ₹50–400 Cr ticket size
• Flexible across minority, significant, or strategic stakes
Ideal opportunities:
• Established business models with clear growth visibility
• ₹50 Cr+ in revenue (flexible for differentiated platforms)
• Strong unit economics and profitable margins
The investor is particularly interested in companies entering a scale-up phase, where strategic capital can accelerate expansion.
If you are a founder, advisor, or intermediary working on relevant opportunities, feel free to reach out.
Type Buy (Investor)
Industry
Hospital / Health Care
Value
₹ 750 Crore
Type Equity (Fundraise)
Industry
Health Care
Value
₹ 1 Crore
Type Equity (Fundraise)
Industry
Health Care
Value
₹ 2 Crore
Type Equity (Fundraise)
Industry
Pharmaceuticals
Value
₹ 1 Crore
Type Equity (Fundraise)
Industry
Electric Vehicles
Value
₹ 10 Crore
Type Equity (Fundraise)
Industry
Sports
Value
₹ 6 Crore
Type Buy (Investor)
Industry
Information Technology / IT
Value
₹ 39.95 Crore
Type Buy (Investor)
Industry
Information Technology / IT
Value
₹ 7.99 Crore
Type Buy (Investor)
Industry
Textiles
Value
₹ 17158.39 Crore
Type Buy (Investor)
Industry
Manufacturing
Value
₹ 100 Crore
Type Buy (Investor)
Industry
Information Technology / IT
Value
₹ 39.95 Crore
INR (₹)